Production (Stage)
Cryo-Cell International, Inc.
CCEL
$4.83
$0.030.63%
AMEX
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | 115.20% | -277.01% | 60.37% | 17.91% | 104.97% |
| Total Depreciation and Amortization | 0.18% | 2.08% | 76.39% | 16.94% | -60.67% |
| Total Amortization of Deferred Charges | -1.89% | 0.00% | 0.00% | 0.00% | -1.85% |
| Total Other Non-Cash Items | 257.57% | 3,150.91% | -101.60% | -4.76% | -96.23% |
| Change in Net Operating Assets | -107.81% | 232.84% | 81.68% | 140.24% | -131.81% |
| Cash from Operations | -55.77% | -11.50% | 37.43% | 596.92% | -110.67% |
| Capital Expenditure | -648.19% | 95.53% | 89.40% | -282.76% | 73.31% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 79.64% | -130.74% | 52.14% | -959.21% | 143.76% |
| Cash from Investing | 74.23% | -67.61% | 75.84% | -707.80% | 82.79% |
| Total Debt Issued | 38.61% | -- | -100.00% | 136.84% | -- |
| Total Debt Repaid | -137.00% | 62.89% | -5,279.58% | 84.34% | 84.38% |
| Issuance of Common Stock | -- | 7,440.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | 100.00% | 98.67% | -626.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00% | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00% | -- | -- |
| Cash from Financing | -48.19% | 66.83% | -269.84% | 123.23% | 134.98% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -192.93% | 233.74% | -222.38% | 239.69% | 10.62% |